| . | Overall . | Matched . | ||||||
|---|---|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | ASD . | CSFD (59) . | Non-CSFD (59) . | P-value . | ASD . |
| Mean age (years) | 76.0 (71.0-81.0) | 77.0 (74.0-81.5) | 0.106 | −0.231 | 76.0 (72.0-82.0) | 77.0 (73.0-79.0) | 0.697 | 0.072 |
| Male sex | 68 (76.4%) | 89 (77.4%) | 0.869 | 0.023 | 45 (76.0%) | 47 (80.0%) | 0.657 | 0.081 |
| Old cerebral infarction | 20 (22.4%) | 43 (37.4%) | 0.043 | −0.286 | 18 (30.5%) | 20 (33.9%) | 0.694 | −0.072 |
| Low ejection fraction (<50%) | 3 (3.4%) | 6 (5.2%) | 0.734 | −0.091 | 1 (1.7%) | 2 (3.4%) | 0.559 | −0.107 |
| Respiratory disorder | 9 (10.1%) | 14 (12.2%) | 0.824 | −0.065 | 6 (10.1%) | 5 (8.5%) | 0.752 | 0.058 |
| Chronic kidney disease (Cr > 1.5) | 21 (23.6%) | 25 (21.7%) | 0.866 | 0.044 | 13 (22.0%) | 14 (23.7%) | 0.827 | −0.040 |
| Antiplatelet therapy | 31 (34.8%) | 55 (47.8%) | 0.065 | −0.265 | 24 (40.8%) | 21 (35.6%) | 0.570 | 0.104 |
| Anticoagulant therapy | 5 (5.6%) | 19 (16.5%) | 0.017 | −0.351 | 5 (8.5%) | 4 (6.8%) | 0.729 | 0.063 |
| Smoking history | 41 (20.7%) | 45 (39.1%) | 0.391 | 0.140 | 28 (47.5%) | 27 (45.8%) | 0.854 | 0.034 |
| Shaggy aorta | 19 (21.3%) | 19 (16.5%) | 0.469 | 0.123 | 12 (20.3%) | 14 (23.7%) | 0.657 | −0.081 |
| Occluded LSCA | 0 | 3 (2.7%) | 0.259 | −0.230 | 0 | 0 | – | – |
| Occluded unilateral HA | 9 (10.1%) | 12 (10.4%) | 0.940 | −0.011 | 7 (11.9%) | 5 (8.5%) | 0.542 | 0.111 |
| Prior descending replacement | 6 (6.7%) | 1 (0.9%) | 0.012 | 0.309 | 0 | 1 (1.7%) | 0.315 | −0.184 |
| Prior intervention on AAA | 26 (29.2%) | 29 (25.2%) | 0.529 | 0.089 | 18 (30.5%) | 15 (25.4%) | 0.538 | 0.113 |
| Iliac access | 33 (37.1%) | 26 (22.6%) | 0.029 | 0.319 | 20 (33.9%) | 19 (32.2%) | 0.845 | 0.036 |
| Zones covered by TEVAR | 7 (6-8) | 7 (5-8) | 0.275 | 0.201 | 7 (6-8) | 6 (5-8) | 0.432 | 0.145 |
| Coverage of the ICA-AKA | 54 (60.1%) | 34 (29.6%) | <0.001 | 0.655 | 26 (44.1%) | 25 (42.4%) | 0.347 | 0.172 |
| Coverage of the coeliac trunk | 6 (6.7%) | 4 (3.5%) | 0.337 | 0.148 | 3 (5.1%) | 3 (5.1%) | 1.000 | −0.000 |
| . | Overall . | Matched . | ||||||
|---|---|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | ASD . | CSFD (59) . | Non-CSFD (59) . | P-value . | ASD . |
| Mean age (years) | 76.0 (71.0-81.0) | 77.0 (74.0-81.5) | 0.106 | −0.231 | 76.0 (72.0-82.0) | 77.0 (73.0-79.0) | 0.697 | 0.072 |
| Male sex | 68 (76.4%) | 89 (77.4%) | 0.869 | 0.023 | 45 (76.0%) | 47 (80.0%) | 0.657 | 0.081 |
| Old cerebral infarction | 20 (22.4%) | 43 (37.4%) | 0.043 | −0.286 | 18 (30.5%) | 20 (33.9%) | 0.694 | −0.072 |
| Low ejection fraction (<50%) | 3 (3.4%) | 6 (5.2%) | 0.734 | −0.091 | 1 (1.7%) | 2 (3.4%) | 0.559 | −0.107 |
| Respiratory disorder | 9 (10.1%) | 14 (12.2%) | 0.824 | −0.065 | 6 (10.1%) | 5 (8.5%) | 0.752 | 0.058 |
| Chronic kidney disease (Cr > 1.5) | 21 (23.6%) | 25 (21.7%) | 0.866 | 0.044 | 13 (22.0%) | 14 (23.7%) | 0.827 | −0.040 |
| Antiplatelet therapy | 31 (34.8%) | 55 (47.8%) | 0.065 | −0.265 | 24 (40.8%) | 21 (35.6%) | 0.570 | 0.104 |
| Anticoagulant therapy | 5 (5.6%) | 19 (16.5%) | 0.017 | −0.351 | 5 (8.5%) | 4 (6.8%) | 0.729 | 0.063 |
| Smoking history | 41 (20.7%) | 45 (39.1%) | 0.391 | 0.140 | 28 (47.5%) | 27 (45.8%) | 0.854 | 0.034 |
| Shaggy aorta | 19 (21.3%) | 19 (16.5%) | 0.469 | 0.123 | 12 (20.3%) | 14 (23.7%) | 0.657 | −0.081 |
| Occluded LSCA | 0 | 3 (2.7%) | 0.259 | −0.230 | 0 | 0 | – | – |
| Occluded unilateral HA | 9 (10.1%) | 12 (10.4%) | 0.940 | −0.011 | 7 (11.9%) | 5 (8.5%) | 0.542 | 0.111 |
| Prior descending replacement | 6 (6.7%) | 1 (0.9%) | 0.012 | 0.309 | 0 | 1 (1.7%) | 0.315 | −0.184 |
| Prior intervention on AAA | 26 (29.2%) | 29 (25.2%) | 0.529 | 0.089 | 18 (30.5%) | 15 (25.4%) | 0.538 | 0.113 |
| Iliac access | 33 (37.1%) | 26 (22.6%) | 0.029 | 0.319 | 20 (33.9%) | 19 (32.2%) | 0.845 | 0.036 |
| Zones covered by TEVAR | 7 (6-8) | 7 (5-8) | 0.275 | 0.201 | 7 (6-8) | 6 (5-8) | 0.432 | 0.145 |
| Coverage of the ICA-AKA | 54 (60.1%) | 34 (29.6%) | <0.001 | 0.655 | 26 (44.1%) | 25 (42.4%) | 0.347 | 0.172 |
| Coverage of the coeliac trunk | 6 (6.7%) | 4 (3.5%) | 0.337 | 0.148 | 3 (5.1%) | 3 (5.1%) | 1.000 | −0.000 |
AAA: abdominal aortic aneurysm; AKA: Adamkiewicz artery; ASD: absolute standardized difference; CSFD: cerebrospinal fluid drainage; Cr: creatinine; HA: hypogastric artery; ICA: intercostal artery; LSCA: left subclavian artery; TEVAR: thoracic endovascular aortic repair.
| . | Overall . | Matched . | ||||||
|---|---|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | ASD . | CSFD (59) . | Non-CSFD (59) . | P-value . | ASD . |
| Mean age (years) | 76.0 (71.0-81.0) | 77.0 (74.0-81.5) | 0.106 | −0.231 | 76.0 (72.0-82.0) | 77.0 (73.0-79.0) | 0.697 | 0.072 |
| Male sex | 68 (76.4%) | 89 (77.4%) | 0.869 | 0.023 | 45 (76.0%) | 47 (80.0%) | 0.657 | 0.081 |
| Old cerebral infarction | 20 (22.4%) | 43 (37.4%) | 0.043 | −0.286 | 18 (30.5%) | 20 (33.9%) | 0.694 | −0.072 |
| Low ejection fraction (<50%) | 3 (3.4%) | 6 (5.2%) | 0.734 | −0.091 | 1 (1.7%) | 2 (3.4%) | 0.559 | −0.107 |
| Respiratory disorder | 9 (10.1%) | 14 (12.2%) | 0.824 | −0.065 | 6 (10.1%) | 5 (8.5%) | 0.752 | 0.058 |
| Chronic kidney disease (Cr > 1.5) | 21 (23.6%) | 25 (21.7%) | 0.866 | 0.044 | 13 (22.0%) | 14 (23.7%) | 0.827 | −0.040 |
| Antiplatelet therapy | 31 (34.8%) | 55 (47.8%) | 0.065 | −0.265 | 24 (40.8%) | 21 (35.6%) | 0.570 | 0.104 |
| Anticoagulant therapy | 5 (5.6%) | 19 (16.5%) | 0.017 | −0.351 | 5 (8.5%) | 4 (6.8%) | 0.729 | 0.063 |
| Smoking history | 41 (20.7%) | 45 (39.1%) | 0.391 | 0.140 | 28 (47.5%) | 27 (45.8%) | 0.854 | 0.034 |
| Shaggy aorta | 19 (21.3%) | 19 (16.5%) | 0.469 | 0.123 | 12 (20.3%) | 14 (23.7%) | 0.657 | −0.081 |
| Occluded LSCA | 0 | 3 (2.7%) | 0.259 | −0.230 | 0 | 0 | – | – |
| Occluded unilateral HA | 9 (10.1%) | 12 (10.4%) | 0.940 | −0.011 | 7 (11.9%) | 5 (8.5%) | 0.542 | 0.111 |
| Prior descending replacement | 6 (6.7%) | 1 (0.9%) | 0.012 | 0.309 | 0 | 1 (1.7%) | 0.315 | −0.184 |
| Prior intervention on AAA | 26 (29.2%) | 29 (25.2%) | 0.529 | 0.089 | 18 (30.5%) | 15 (25.4%) | 0.538 | 0.113 |
| Iliac access | 33 (37.1%) | 26 (22.6%) | 0.029 | 0.319 | 20 (33.9%) | 19 (32.2%) | 0.845 | 0.036 |
| Zones covered by TEVAR | 7 (6-8) | 7 (5-8) | 0.275 | 0.201 | 7 (6-8) | 6 (5-8) | 0.432 | 0.145 |
| Coverage of the ICA-AKA | 54 (60.1%) | 34 (29.6%) | <0.001 | 0.655 | 26 (44.1%) | 25 (42.4%) | 0.347 | 0.172 |
| Coverage of the coeliac trunk | 6 (6.7%) | 4 (3.5%) | 0.337 | 0.148 | 3 (5.1%) | 3 (5.1%) | 1.000 | −0.000 |
| . | Overall . | Matched . | ||||||
|---|---|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | ASD . | CSFD (59) . | Non-CSFD (59) . | P-value . | ASD . |
| Mean age (years) | 76.0 (71.0-81.0) | 77.0 (74.0-81.5) | 0.106 | −0.231 | 76.0 (72.0-82.0) | 77.0 (73.0-79.0) | 0.697 | 0.072 |
| Male sex | 68 (76.4%) | 89 (77.4%) | 0.869 | 0.023 | 45 (76.0%) | 47 (80.0%) | 0.657 | 0.081 |
| Old cerebral infarction | 20 (22.4%) | 43 (37.4%) | 0.043 | −0.286 | 18 (30.5%) | 20 (33.9%) | 0.694 | −0.072 |
| Low ejection fraction (<50%) | 3 (3.4%) | 6 (5.2%) | 0.734 | −0.091 | 1 (1.7%) | 2 (3.4%) | 0.559 | −0.107 |
| Respiratory disorder | 9 (10.1%) | 14 (12.2%) | 0.824 | −0.065 | 6 (10.1%) | 5 (8.5%) | 0.752 | 0.058 |
| Chronic kidney disease (Cr > 1.5) | 21 (23.6%) | 25 (21.7%) | 0.866 | 0.044 | 13 (22.0%) | 14 (23.7%) | 0.827 | −0.040 |
| Antiplatelet therapy | 31 (34.8%) | 55 (47.8%) | 0.065 | −0.265 | 24 (40.8%) | 21 (35.6%) | 0.570 | 0.104 |
| Anticoagulant therapy | 5 (5.6%) | 19 (16.5%) | 0.017 | −0.351 | 5 (8.5%) | 4 (6.8%) | 0.729 | 0.063 |
| Smoking history | 41 (20.7%) | 45 (39.1%) | 0.391 | 0.140 | 28 (47.5%) | 27 (45.8%) | 0.854 | 0.034 |
| Shaggy aorta | 19 (21.3%) | 19 (16.5%) | 0.469 | 0.123 | 12 (20.3%) | 14 (23.7%) | 0.657 | −0.081 |
| Occluded LSCA | 0 | 3 (2.7%) | 0.259 | −0.230 | 0 | 0 | – | – |
| Occluded unilateral HA | 9 (10.1%) | 12 (10.4%) | 0.940 | −0.011 | 7 (11.9%) | 5 (8.5%) | 0.542 | 0.111 |
| Prior descending replacement | 6 (6.7%) | 1 (0.9%) | 0.012 | 0.309 | 0 | 1 (1.7%) | 0.315 | −0.184 |
| Prior intervention on AAA | 26 (29.2%) | 29 (25.2%) | 0.529 | 0.089 | 18 (30.5%) | 15 (25.4%) | 0.538 | 0.113 |
| Iliac access | 33 (37.1%) | 26 (22.6%) | 0.029 | 0.319 | 20 (33.9%) | 19 (32.2%) | 0.845 | 0.036 |
| Zones covered by TEVAR | 7 (6-8) | 7 (5-8) | 0.275 | 0.201 | 7 (6-8) | 6 (5-8) | 0.432 | 0.145 |
| Coverage of the ICA-AKA | 54 (60.1%) | 34 (29.6%) | <0.001 | 0.655 | 26 (44.1%) | 25 (42.4%) | 0.347 | 0.172 |
| Coverage of the coeliac trunk | 6 (6.7%) | 4 (3.5%) | 0.337 | 0.148 | 3 (5.1%) | 3 (5.1%) | 1.000 | −0.000 |
AAA: abdominal aortic aneurysm; AKA: Adamkiewicz artery; ASD: absolute standardized difference; CSFD: cerebrospinal fluid drainage; Cr: creatinine; HA: hypogastric artery; ICA: intercostal artery; LSCA: left subclavian artery; TEVAR: thoracic endovascular aortic repair.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
